About Keimed
Keimed is a company based in Hyderabad (India) founded in 2000. Keimed has raised $16.62 million across 2 funding rounds from investors including Mitsui & Co and Apollo Hospitals. The company has 420 employees as of April 05, 2024. Keimed offers products and services including Medicine Distribution Service and Cold Chain Logistics. Keimed operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Sandor Medicaids, Mahaveer Medi Sales and Maypharm Life Sciences, among others.
- Headquarter Hyderabad, India
- Employees 420 as on 05 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Keimed Private Limited
- Date of Incorporation 10 Mar, 2000
- Jurisdiction Chennai City Corporation, Tamil Nadu, India
-
Annual Revenue
$1.15 B (USD)25.08as on Mar 31, 2023
-
Net Profit
$10.68 M (USD)-5.77as on Mar 31, 2023
-
EBITDA
$40.52 M (USD)22.15as on Mar 31, 2023
-
Total Equity Funding
$16.62 M (USD)
in 2 rounds
-
Latest Funding Round
$11.7 M (USD), Series B
Mar 20, 2025
-
Investors
Mitsui & Co.
& 1 more
-
Employee Count
420
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Keimed
Keimed offers a comprehensive portfolio of products and services, including Medicine Distribution Service and Cold Chain Logistics.
Provides nationwide delivery of genuine, temperature-controlled medicines.
Ensures integrity of temperature-sensitive healthcare products during transport.
People of Keimed
Unlock access to complete
Funding Insights of Keimed
Keimed has successfully raised a total of $16.62M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $11.7 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $11.7M
-
First Round
First Round
(13 Aug 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series B - Keimed | Valuation | Apollo Hospitals |
|
| Aug, 2015 | Amount | Series A - Keimed | Valuation | Mitsui |
|
Investors in Keimed
Keimed has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Mitsui & Co and Apollo Hospitals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Traditional conglomerate services are provided across multiple sectors by Mitsui.
|
Founded Year | Domain | Location | |
|
Chain of multispecialty hospitals
|
Founded Year | Domain | Location |
Investments & Acquisitions by Keimed
Financial Statements - Keimed
Keimed Comparisons
Competitors of Keimed
Keimed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Sandor Medicaids, Mahaveer Medi Sales and Maypharm Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
India's leading healthcare products distribution platform
|
|
| domain | founded_year | HQ Location |
Provider of medical equipment, devices, and drugs distribution services
|
|
| domain | founded_year | HQ Location |
Serves as a distributor of a wide range of pharmaceutical drugs.
|
|
| domain | founded_year | HQ Location |
Delivers healthcare products, regulatory support, and business consulting in Latin America.
|
Frequently Asked Questions about Keimed
Keimed was founded in 2000 and raised its 1st funding round 15 years after it was founded.
Keimed is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Gaurav Chaturvedi is the current CEO of Keimed.
Keimed is a funded company, having raised a total of $16.62M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.92M, raised on Aug 13, 2015.
As of Apr 05, 2024, the latest employee count at Keimed is 420.
Annual revenue of Keimed is $1.15B as on Mar 31, 2023.
Founded in 2000 in Hyderabad, India, Keimed operates in the pharmaceutical distribution sector. Temperature-sensitive medicines are sourced directly from manufacturers and stored in specialized facilities to preserve quality and effectiveness. A rapid logistics system is employed for timely deliveries, supported by advanced cold chain infrastructure and technology. Operations focus on efficiency across the supply chain in the Indian market.
Keimed's top competitors include Entero Healthcare, AmerisourceBergen and Sandor Medicaids.
Keimed offers Medicine Distribution Service and Cold Chain Logistics.
Keimed has 2 investors. Key investors include Mitsui & Co, and Apollo Hospitals.
The valuation of Keimed is $122.86M as of Aug 2015.